S. Wrigley

Differential regulation of CD3- and CD28-induced IL-2 and IFN-gamma production by a novel tyrosine kinase inhibitor XR774 from Cladosporium cf. cladosporioides.

B. Foxwell, A. Manić, P. Rawlins, 2001, International immunopharmacology.

Inhibition of endotoxin-induced TNF-alpha production in macrophages by 5Z-7-oxo-zeaenol and other fungal resorcylic acid lactones.

B. Foxwell, P. Rawlins, G. Gammon, 1999, International journal of immunopharmacology.

CD4-binding compounds: an assay to detect new classes of immunopharmacological agents.

J. Mous, M. Malkovský, P. Depledge, 1993, International journal of immunopharmacology.

2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity.

K. Paull, M. Stevens, R. Schultz, 1998, British Journal of Cancer.

Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.

S Wrigley, M. Stevens, T. Bradshaw, 1996, Journal of medicinal chemistry.

Antitumor benzothiazoles. 7. Synthesis of 2-(4-acylaminophenyl)benzothiazoles and investigations into the role of acetylation in the antitumor activities of the parent amines.

M. Stevens, D. Barrett, T. Bradshaw, 1999, Journal of medicinal chemistry.

Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo.

K. Paull, L. Kèlland, M. Stevens, 1998, British Journal of Cancer.

Antitumor Benzothiazoles. Part 3. Synthesis of 2‐(4‐Aminophenyl) benzothiazoles and Evaluation of Their Activities Against Breast Cancer Cell Lines in vitro and in vivo.

M. Stevens, T. Bradshaw, P. Lelieveld, 1996 .